OR WAIT null SECS
Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.
More than 90% of patients in hypertension and lipid management accomplished their predetermined goals after completing the remote program.
A remote lipid and hypertension program could increase medication adherence and improve overall care, while also closing some of the racial and regional discrepancies that exist in cardiovascular care.
In a late-breaking abstract presented during the 2021 American Heart Association (AHA) Scientific Sessions, investigators from Massachusetts General Hospital and Brigham and Women’s Hospital, found in a study of 10,000 patients that standardized, remote, algorithmic care can effectively optimize and complement guideline-directed therapy at scale, reduce cardiovascular risk, and minimize the need for in-person visits
In an interview with HCPLive®, Alexander Blood, MD, Clinical Fellow in Medicine, Brigham and Women’s Hospital, explained how the results of the study prove there is a way to close some of the gaps that are persistent in medicine.
In the study, enrolled patients into a remote hypertension and lipids education and management program that included an end-to-end disease management solution with identification, engagement, device integration, education, and medication titration.
The program also included non-licensed navigators, supervised by a team of pharmacists, nurse practitioners and physicians coordinated care using customer relationship management software, task automation, and omni-channel communication.
In the hypertension program, 92% of patients reached their blood pressure goals, while in the lipids program, 94% of patients reached their LDL-C goal.